Table 2 Baseline characteristics after propensity score matching
Characteristics | Age ≤ 45 years (n = 51) | Age > 45 years (n = 51) | P value |
|---|---|---|---|
Sex | 0.074 | ||
Male | 22 (43.1%) | 31 (60.8%) | |
Female | 29 (56.9%) | 20 (39.2%) | |
BMI (kg/m2) | 21.9 ± 3.9 | 21.5 ± 3.4 | 0.584 |
Comorbidities | 7 (13.7%) | 9 (17.6%) | 0.586 |
Neo-adjuvant chemotherapy | 4 (7.8%) | 7 (13.7%) | 0.338 |
Pre-operative hemoglobin (g/L) | 124.5 ± 29.3 | 121.7 ± 24.3 | 0.600 |
Pre-operative albumin (g/L) | 43.6 ± 4.9 | 42.1 ± 7.9 | 0.274 |
Type of resection | 0.413 | ||
Subtotal gastrectomy | 34 (66.7%) | 30 (60.8%) | |
Total gastrectomy | 17 (33.3%) | 21 (39.2%) | |
Laparoscopy surgery | 49 (96.1%) | 50 (98.0%) | 1.000 |
Reconstruction methods | 0.797 | ||
B-I | 21 (41.2%) | 18 (35.3%) | |
B-II | 9 (17.6%) | 11 (21.6%) | |
R-Y | 21 (41.2%) | 22 (43.1%) | |
pTNM stage | 0.318 | ||
I | 23 (45.1%) | 16 (31.4%) | |
II | 13 (25.5%) | 14 (27.5%) | |
III | 15 (29.4%) | 21 (41.2%) | |